Related Experiment Video
Updated: Jul 11, 2025

Functional Evaluation of Biological Neurotoxins in Networked Cultures of Stem Cell-derived Central Nervous System Neurons
Published on: February 5, 2015
RTP801 mediates transneuronal toxicity in culture via extracellular vesicles
Júlia Solana-Balaguer1,2,3, Núria Martín-Flores1,2, Pol Garcia-Segura1,2,3
1Department of Biomedical Sciences, Universitat de Barcelona, Barcelona, Spain.
Abstract:
Extracellular vesicles (EVs) play a crucial role in intercellular communication, participating in the paracrine trophic support or in the propagation of toxic molecules, including proteins. RTP801 is a stress-regulated protein, whose levels are elevated during neurodegeneration and induce neuron death. However, whether RTP801 toxicity is transferred trans-neuronally via EVs remains unknown. Hence, we overexpressed or silenced RTP801 protein in cultured cortical neurons, isolated their derived EVs (RTP801-EVs or shRTP801-EVs, respectively), and characterized EVs protein content by mass spectrometry (MS). RTP801-EVs toxicity was assessed by treating cultured neurons with these EVs and quantifying apoptotic neuron death and branching. We also tested shRTP801-EVs functionality in the pathologic in vitro model of 6-Hydroxydopamine (6-OHDA). Expression of RTP801 increased the number of EVs released by neurons. Moreover, RTP801 led to a distinct proteomic signature of neuron-derived EVs, containing more pro-apoptotic markers. Hence, we observed that RTP801-induced toxicity was transferred to neurons via EVs, activating apoptosis and impairing neuron morphology complexity. In contrast, shRTP801-EVs were able to increase the arborization in recipient neurons. The 6-OHDA neurotoxin elevated levels of RTP801 in EVs, and 6-OHDA-derived EVs lost the mTOR/Akt signalling activation via Akt and RPS6 downstream effectors. Interestingly, EVs derived from neurons where RTP801 was silenced prior to exposing them to 6-OHDA maintained Akt and RPS6 transactivation in recipient neurons. Taken together, these results suggest that RTP801-induced toxicity is transferred via EVs, and therefore, it could contribute to the progression of neurodegenerative diseases, in which RTP801 is involved.
Insights
Toxicity from the RTP801 protein can spread between neurons through extracellular vesicles (EVs), contributing to neurodegeneration. Silencing RTP801 in EVs protected neurons and maintained essential signaling pathways.
Area of Science:
- Neuroscience
- Cell Biology
- Biochemistry
Background:
- Extracellular vesicles (EVs) mediate intercellular communication, transferring molecules between cells.
- RTP801 is a stress-induced protein linked to neurodegeneration and neuronal death.
- The trans-neuronal transfer of RTP801 toxicity via EVs is not well understood.
Purpose of the Study:
- To investigate whether RTP801 toxicity is transferred between neurons via EVs.
- To determine the role of RTP801 in the proteomic signature and function of neuron-derived EVs.
- To assess the impact of RTP801-carrying EVs on neuronal apoptosis and morphology.
Main Methods:
- Overexpression and silencing of RTP801 in cultured cortical neurons.
- Isolation and mass spectrometry-based proteomic characterization of neuron-derived EVs.
- Treatment of recipient neurons with engineered EVs and assessment of apoptosis, morphology, and signaling pathways (mTOR/Akt).
- Utilizing a 6-Hydroxydopamine (6-OHDA) in vitro model of neurodegeneration.
Main Results:
- RTP801 overexpression increased EV release and altered EV proteomic content, including pro-apoptotic markers.
- RTP801-containing EVs induced apoptosis and reduced neuronal branching, confirming trans-neuronal toxicity transfer.
- EVs from RTP801-silenced neurons (shRTP801-EVs) promoted neuronal arborization.
- 6-OHDA treatment increased RTP801 in EVs and impaired Akt/RPS6 signaling; this impairment was rescued by shRTP801-EVs.
Conclusions:
- RTP801 toxicity is transferable between neurons via EVs, contributing to neurodegenerative processes.
- EVs carrying RTP801 can propagate neuronal damage and disrupt critical signaling pathways.
- Targeting RTP801 within EVs may offer a therapeutic strategy for neurodegenerative diseases.

